Skip to main content
. 2024 Jan 18;13:1268584. doi: 10.3389/fonc.2023.1268584

Figure 2.

Figure 2

One-way sensitivity analysis tornado diagram of the incremental cost–effectiveness ratio (cost per quality-adjusted life-year gained) of toripalimab plus chemotherapy versus chemotherapy.